Literature DB >> 13973597

The evaluation and current concept of retinoblastoma therapy.

A B REESE, R M ELLSWORTH.   

Abstract

Entities:  

Keywords:  ANTINEOPLASTIC AGENTS; RADIUM; RADON; RETINOBLASTOMA

Mesh：

Substances：

Year:  1963        PMID： 13973597

Source DB:  PubMed          Journal:  Trans Am Acad Ophthalmol Otolaryngol        ISSN： 0002-7154


× No keyword cloud information.
  49 in total

1.  Access to the ophthalmic artery by retrograde approach through the posterior communicating artery for intra-arterial chemotherapy of retinoblastoma.

Authors:  Chi-Tuan Pham; Raphaël Blanc; L Lumbroso-Le Rouic; Livia Lumbroso-Le Rouic; Silvia Pistocchi; Bruno Bartolini; Michel Piotin
Journal:  Neuroradiology       Date:  2011-11-18       Impact factor: 2.804

2.  High-risk retinoblastoma based on age at primary enucleation: a study of 616 eyes.

Authors:  Swathi Kaliki; Shweta Gupta; George Ramappa; Ashik Mohamed; Dilip K Mishra
Journal:  Eye (Lond)       Date:  2019-11-25       Impact factor: 3.775

3.  Comparison of high-risk histopathological features in eyes with primary or secondary enucleation for retinoblastoma.

Authors:  Rachel C Brennan; Ibrahim Qaddoumi; Catherine A Billups; Tammy L Free; Barrett G Haik; Carlos Rodriguez-Galindo; Matthew W Wilson
Journal:  Br J Ophthalmol       Date:  2015-04-14       Impact factor: 4.638

Review 4.  Retinoblastoma, the visible CNS tumor: A review.

Authors:  Helen Dimaras; Timothy W Corson
Journal:  J Neurosci Res       Date:  2018-01-03       Impact factor: 4.164

5.  Retinoblastoma. Fifty years of progress. The LXXI Edward Jackson Memorial Lecture.

Authors:  Hans E Grossniklaus
Journal:  Am J Ophthalmol       Date:  2014-07-24       Impact factor: 5.258

6.  Developmental and adaptive functioning in children with retinoblastoma: a longitudinal investigation.

Authors:  Victoria W Willard; Ibrahim Qaddoumi; Si Chen; Hui Zhang; Rachel Brennan; Carlos Rodriguez-Galindo; Matthew W Wilson; Sean Phipps
Journal:  J Clin Oncol       Date:  2014-07-14       Impact factor: 44.544

7.  Patients with retinoblastoma and chromosome 13q deletions have increased chemotherapy-related toxicities.

Authors:  Rachel C Brennan; Ibrahim Qaddoumi; Catherine A Billups; Tracy Kaluzny; Wayne L Furman; Matthew W Wilson
Journal:  Pediatr Blood Cancer       Date:  2016-07-13       Impact factor: 3.167

8.  Chemoreduction for retinoblastoma: analysis of tumor control and risks for recurrence in 457 tumors.

Authors:  Carol L Shields; Arman Mashayekhi; Jacqueline Cater; Abdallah Shelil; Anna T Meadows; Jerry A Shields
Journal:  Trans Am Ophthalmol Soc       Date:  2004

9.  Tumor Environment of Retinoblastoma, Intraocular Cancer.

Authors:  Dong Hyun Jo; Jin Hyoung Kim; Jeong Hun Kim
Journal:  Adv Exp Med Biol       Date:  2020       Impact factor: 2.622

10.  External beam radiotherapy for retinoblastoma: II. Lens sparing technique.

Authors:  N M Toma; J L Hungerford; P N Plowman; J E Kingston; D Doughty
Journal:  Br J Ophthalmol       Date:  1995-02       Impact factor: 4.638
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.